Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Rosmarinic Acid.
Rosmarinic acid is a polyphenolic carboxylic acid that exerts potent antioxidant and anti-inflammatory effects by modulating the Nrf2 signaling pathway and inhibiting cyclooxygenase-2 (COX-2) activity.
5281792
360.3 g/mol
2.4
(2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxypropanoic acid
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Rosmarinic Acid across standard consumer modalities.
The hygroscopic nature of rosmarinic acid necessitates the use of moisture-barrier excipients to maintain powder flowability and chemical stability.
The inherent acidity of the molecule can disrupt pectin cross-linking, requiring careful pH adjustment to ensure proper gel strength and texture.
Limited aqueous solubility and the requirement for relatively high therapeutic doses pose significant challenges for achieving a uniform payload within the thin-film matrix.
Ready to launch a product featuring Rosmarinic Acid? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Rosmarinic Acid extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Rosmarinic Acid payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation